These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3290383)

  • 21. Toward the development of an antidisease, transmission-blocking intranasal vaccine for group a streptococcus.
    Batzloff MR; Yan H; Davies MR; Hartas J; Lowell GH; White G; Burt DS; Leanderson T; Good MF
    J Infect Dis; 2005 Oct; 192(8):1450-5. PubMed ID: 16170764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of a mucosal immune response to the streptococcal M protein by intramuscular administration of a PADRE-ASREAK peptide.
    Pamonsinlapatham P; Decroix N; Mihaila-Amrouche L; Bouvet A; Bouvet JP
    Scand J Immunol; 2004 May; 59(5):504-10. PubMed ID: 15140061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination equally enables both genetically susceptible and resistant mice to control infection with group A streptococci.
    Siegert J; Sastalla I; Chhatwal GS; Medina E
    Microbes Infect; 2006 Feb; 8(2):347-53. PubMed ID: 16213175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of local immunity to group A streptococci type M50 in mice by non-type-specific mechanisms.
    Kurl DN; Stjernquist-Desatnik A; Schalén C; Christensen P
    Acta Pathol Microbiol Immunol Scand B; 1985 Dec; 93(6):401-5. PubMed ID: 3914820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral immunization of mice with engineered Lactobacillus gasseri NM713 strain expressing Streptococcus pyogenes M6 antigen.
    Mansour NM; Abdelaziz SA
    Microbiol Immunol; 2016 Aug; 60(8):527-32. PubMed ID: 27301486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of antibacterial immunity of mucous membranes.
    Franĕk J; Libich J; Kubín V
    Folia Microbiol (Praha); 1984; 29(5):375-84. PubMed ID: 6500406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of secretory antibodies in the defence against infections.
    Brandtzaeg P
    Int J Med Microbiol; 2003 Apr; 293(1):3-15. PubMed ID: 12755363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with C5a peptidase from either group A or B streptococci enhances clearance of group A streptococci from intranasally infected mice.
    Cleary PP; Matsuka YV; Huynh T; Lam H; Olmsted SB
    Vaccine; 2004 Oct; 22(31-32):4332-41. PubMed ID: 15474726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation.
    Olive C; Schulze K; Sun HK; Ebensen T; Horváth A; Toth I; Guzman CA
    Vaccine; 2007 Feb; 25(10):1789-97. PubMed ID: 17229503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal vaccination with streptococcal fibronectin binding protein Sfb1 fails to prevent growth and dissemination of Streptococcus pyogenes in a murine skin infection model.
    McArthur J; Medina E; Mueller A; Chin J; Currie BJ; Sriprakash KS; Talay SR; Chhatwal GS; Walker MJ
    Infect Immun; 2004 Dec; 72(12):7342-5. PubMed ID: 15557665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-Activation of Th17 and Antibody Responses Provides Efficient Protection against Mucosal Infection by Group A Streptococcus.
    Chen X; Li N; Bi S; Wang X; Wang B
    PLoS One; 2016; 11(12):e0168861. PubMed ID: 28030629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes.
    Schulze K; Olive C; Ebensen T; Guzmán CA
    Vaccine; 2006 Aug; 24(35-36):6088-95. PubMed ID: 16828529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hybridoma antibodies against protective and nonprotective antigenic determinants of a structurally defined polypeptide fragment of streptococcal M protein.
    Hasty DL; Beachey EH; Simpson WA; Dale JB
    J Exp Med; 1982 Apr; 155(4):1010-8. PubMed ID: 6174666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the opsonic activity of purified bovine sIgA following intramammary immunization of cows with Staphylococcus aureus.
    Barrio MB; Rainard P; Gilbert FB; Poutrel B
    J Dairy Sci; 2003 Sep; 86(9):2884-94. PubMed ID: 14507024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci.
    Kapur V; Maffei JT; Greer RS; Li LL; Adams GJ; Musser JM
    Microb Pathog; 1994 Jun; 16(6):443-50. PubMed ID: 7830531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus.
    Ji Y; Carlson B; Kondagunta A; Cleary PP
    Infect Immun; 1997 Jun; 65(6):2080-7. PubMed ID: 9169735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization with Streptococcal Heme Binding Protein (Shp) Protects Mice Against Group A Streptococcus Infection.
    Zhang X; Song Y; Li Y; Cai M; Meng Y; Zhu H
    Adv Exp Med Biol; 2017; 973():115-124. PubMed ID: 28190144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS).
    Rivera-Hernandez T; Hartas J; Wu Y; Chuan YP; Lua LH; Good M; Batzloff MR; Middelberg AP
    Vaccine; 2013 Apr; 31(15):1950-5. PubMed ID: 23422147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.
    Boyaka PN
    J Immunol; 2017 Jul; 199(1):9-16. PubMed ID: 28630108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [What is the purpose of mucosal antibodies? Relevance to colonization with group B streptococci].
    Hordnes K; Jonsson R; Brandtzaeg P; Haneberg B
    Tidsskr Nor Laegeforen; 1997 Nov; 117(28):4109-13. PubMed ID: 9441448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.